|
Feb 24
|
5 Stocks in the Dow ETF That Survived the Worst Week Since October
|
|
Feb 24
|
Merck to Participate in the TD Cowen 45th Annual Health Care Conference
|
|
Feb 23
|
Merck & Co., Inc. (MRK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
|
|
Feb 22
|
Merck & Co., Inc. (MRK): Among the Most Expensive Stocks Insiders Are Buying Recently
|
|
Feb 21
|
2 Healthcare Stocks with Big Upside and 1 to Skip
|
|
Feb 18
|
Merck & Co., Inc. (MRK): Among the Cheap High Dividend Stocks to Invest In Now
|
|
Feb 18
|
Is Merck & Co., Inc. (MRK) the Best Very Cheap Stock To Buy Right Now?
|
|
Feb 18
|
Europe Approves Merck's Cancer Drug For Two Indications
|
|
Feb 18
|
Merck & Co., Inc. (MRK): Among the Best Drug Stocks to Buy Now
|
|
Feb 18
|
WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications
|
|
Feb 17
|
Is Merck & Co., Inc. (MRK) the Most Oversold S&P 500 Stock in 2024?
|
|
Feb 15
|
Jim Cramer Comments on Merck & Co., Inc. (MRK) and Its China Woes
|
|
Feb 13
|
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
|
|
Feb 13
|
Merck & Co., Inc. (MRK): A Bull Case Theory
|
|
Feb 13
|
US pharma giant Merck backs healthcare marketplace HD in Southeast Asia
|
|
Feb 12
|
Why Merck & Co., Inc. (MRK) is Declining
|
|
Feb 11
|
Jim Cramer on Merck & Co., Inc. (MRK): ‘Drug Stocks Are Really Getting Hurt’
|
|
Feb 11
|
Health Canada Approves Merck's KEYTRUDA® (pembrolizumab) for the treatment of adult patients with resectable Stage II, IIIA, or IIIB (T3-4N2) non-small cell lung carcinoma (NSCLC) in combination with platinum-containing chemotherapy as neoadjuvant trea...
|
|
Feb 11
|
In the crowded cardio space, it’s David vs. Goliath for small biotechs
|
|
Jan 6
|
Merck to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
|